From: Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study
Treatment group
Coefficient (β)
AI Robust Standard Errors
p
95% CI
AZT
Base Regimen
ABC
ATE
0.0112
0.0566
0.844
−0.0998, 0.1221
ATET
0.0217
0.0750
0.772
−0.1253, 0.1688